Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)
Clinical trial NCT00992589 · COMPLETED
Trial details
- NCT number
- NCT00992589
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-11-01
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.